Anemia and Blood Transfusions in the Intensive Care Unit: A Review

Sakhr Alshwayyat; Majdeddin MohammedAli; Hamza Nakhleh; Azzam Ali Almomani; Mohammed J. Al-Jaghbeer

doi:10.58877/japaj.v2i1.124

Authors

Sakhr Alshwayyat Jordan University of Science and Technology
Majdeddin MohammedAli Faculty of Medicine and Health Science, An-Najah National University, Nablus, Palestine
Hamza Nakhleh The National Centre Institute for Diabetes, Endocrinology and Genetics, Amman, Jordan
Azzam Ali Almomani Division of Anesthesia and ICU, Department of Anesthesia, Ministry of Health – Al-Basheer Hospital, Amman
Mohammed J. Al-Jaghbeer Department of Internal Medicine, King Hussein Cancer Center and Foundation, Amman, Jordan.

DOI:

https://doi.org/10.58877/japaj.v2i1.124

Keywords:

Anemia, Critical illness, Intensive care units, Transfusion reactions

Abstract

Anemia is common among critically ill patients and can be iatrogenic. Its prevalence is influenced by various factors, such as age, comorbidities, and transfusion practices. Blood transfusion remains a pervasive practice with most critically ill patients receiving blood. The decision to transfuse blood in the ICU should be individualized considering the patient's clinical status and comorbidities. Recent studies have highlighted the safety and effectiveness of a restrictive transfusion strategy that can reduce the risk of transfusion-related complications. However, it is crucial to consider the specific needs of certain patient populations, such as those with cardiovascular diseases. Workup starts with a directed history and examination, followed by tailored investigations to answer specific questions. Massive transfusions, when indicated, requires a multidisciplinary team to be orchestrated by the physician and requires knowledge of the criteria for implementing a Massive Transfusion Protocol (MTP), as well as the logistical aspects of obtaining and transfusing blood products. Thromboelastography (TEG) can be a useful tool for guiding blood transfusions in such cases. Transfusion reactions (TR) are potential complications of blood transfusion with varying presentations and degrees of severity. This article delves into the different types of TR, their clinical manifestations, and the necessary workup and management steps, emphasizing the importance of timely intervention.

References

Walsh TS and Saleh EED. Anaemia during critical illness. Br J Anaesth. 2006 Sep;97(3):278-91 DOI: https://doi.org/10.1093/bja/ael189

Abdo N, Douglas S, Batieha A, Khader Y, Jaddou H, Al-Khatib S, et al. The prevalence and determinants of anaemia in Jordan. East Mediterr Health J. 2019 Jul 24;25(5):341-349 DOI: https://doi.org/10.26719/emhj.18.047

3. Louis Vincent J, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and Blood Transfusion in Critically Ill Patients JAMA. 2002 Sep 25;288(12):1499-507. DOI: https://doi.org/10.1001/jama.288.12.1499

Nguyen BV, Bota DP, Melot C, Vincent JL. Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med 2003; 31: 406–10 DOI: https://doi.org/10.1097/01.CCM.0000048623.00778.3F

Rawal G, Kumar R, Yadav S, Singh A. Anemia in Intensive Care: A review of Current Concepts. The Journal of Critical Care Medicine. 2016 Jul 1;2(3):109–14. DOI: https://doi.org/10.1515/jccm-2016-0017

Boshuizen M, Binnekade JM, Nota B, van de Groep K, Cremer OL, Tuinman PR, et al. Iron metabolism in critically ill patients developing anemia of inflammation: a case control study. Ann Intensive Care. 2018 Dec 1;8(1). DOI: https://doi.org/10.1186/s13613-018-0407-5

Ben-Menachem T, Fogel R, Patel R V, Touchette M, Zarowitz BJ, Hadzijahic N, et al. Prophylaxis for Stress-related Gastric Hemorrhage in the Medical Intensive Care Unit A Randomized, Controlled, Single-Blind Study [Internet]. Vol. 121, Ann Intern Med. 1994. Available from: http://annals.org/pdfaccess.ashx?url=/data/journals/aim/19816/ DOI: https://doi.org/10.7326/0003-4819-121-8-199410150-00003

McEvoy MT, Shander A. Anemia, bleeding, and blood transfusion in the intensive care unit: Causes, risks, costs, and new strategies. American Journal of Critical Care. 2013 Nov 1;22(6). DOI: https://doi.org/10.4037/ajcc2013729

Chant C, Wilson G, Friedrich JO. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: A cohort study. Crit Care. 2006 Sep 26;10(5).

Arnold DM, Donahoe L, Clarke FJ, Tkaczyk AJ, Heels-Ansdell D, Zytaruk N, et al. Bleeding during critical illness: A prospective cohort study using a new measurement tool. 2007. DOI: https://doi.org/10.25011/cim.v30i2.985

Shander A. Anemia in the critically ill. Vol. 20, Critical Care Clinics. 2004. p. 159–78. DOI: https://doi.org/10.1016/j.ccc.2004.01.002

Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Walker HK, Hall WD, Hurst JW, editors. Boston: Butterworths; 1990.

Pfeiffer CM, Looker AC. Laboratory methodologies for indicators of iron status: strengths, limitations, and analytical challenges. Am J Clin Nutr [Internet]. 2017;106:1606–20. Available from: https://doi.org/10.3945/ajcn. DOI: https://doi.org/10.3945/ajcn.117.155887

Rohr M, Brandenburg V, Brunner-La Rocca HP. How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome. Vol. 28, European Journal of Medical Research. BioMed Central Ltd; 2023. DOI: https://doi.org/10.1186/s40001-022-00922-6

Zuther M, Rübsam ML, Zimmermann M, Zarbock A, Hönemann C. Improved Diagnosis of Iron Deficiency Anemia in the Critically Ill via Fluorescence Flowcytometric Hemoglobin Biomarkers. Cells. 2023 Jan 1;12(1). DOI: https://doi.org/10.3390/cells12010140

Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of Serum Methylmalonic Acid and Total Homocysteine Determinations for Diagnosing Cobalamin and Folate Deficiencies.

Nagao T, Hirokawa M. Diagnosis and treatment of macrocytic anemias in adults. Vol. 18, Journal of General and Family Medicine. Wiley-Blackwell; 2017. p. 200–4. DOI: https://doi.org/10.1002/jgf2.31

Shih AWY, Mcfarlane A, Verhovsek M. Haptoglobin testing in hemolysis: Measurement and interpretation. Am J Hematol. 2014;89(4):443–7. DOI: https://doi.org/10.1002/ajh.23623

Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med. 2006;34(2):344–53. DOI: https://doi.org/10.1097/01.CCM.0000194725.48928.3A

Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, et al. Transfusion thresholds for guiding red blood cell transfusion. Vol. 2021, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2021. DOI: https://doi.org/10.1002/14651858.CD002042.pub5

Shander A, Goodnough LT. From tolerating anemia to treating anemia. Vol. 170, Annals of Internal Medicine. American College of Physicians; 2019. p. 125–6. DOI: https://doi.org/10.7326/M18-3145

Roubinian NH, Escobar GJ, Liu V, Gardner MN, Carson JL, Kleinman SH, et al. Decreased red blood cell use and mortality in hospitalized patients. Vol. 174, JAMA Internal Medicine. American Medical Association; 2014. p. 1405–7. DOI: https://doi.org/10.1001/jamainternmed.2014.2889

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, et al. Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion (Paris). 2014 Oct 1;54(1):2678–86. DOI: https://doi.org/10.1111/trf.12825

Roubinian NH, Murphy EL, Mark DG, Triulzi DJ, Carson JL, Lee C, et al. Long-term outcomes among patients discharged from the hospital with moderate anemia a retrospective cohort study. Ann Intern Med. 2019 Jan 15;170(2):81–9. DOI: https://doi.org/10.7326/M17-3253

Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: A meta-analysis and systematic review. American Journal of Medicine. 2014;127(2). DOI: https://doi.org/10.1016/j.amjmed.2013.09.017

Hovaguimian F, Myles PS. Restrictive versus Liberal Transfusion Strategy in the Perioperative and Acute Care Settings: A Context-specific Systematic Review and Meta-analysis of Randomized Controlled Trials. Anesthesiology. 2016 Jul 1;125(1):46–61. DOI: https://doi.org/10.1097/ALN.0000000000001162

Simon GI, Craswell A, Thom O, Fung YL. Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis. Lancet Haematol. 2017 Oct 1;4(10):e465–74. DOI: https://doi.org/10.1016/S2352-3026(17)30141-2

Meybohm P, Lindau S, Treskatsch S, Francis R, Spies C, Velten M, et al. Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - The study design of the LIBERAL-Trial. Trials. 2019 Feb 4;20(1). DOI: https://doi.org/10.1186/s13063-019-3200-3

Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, et al. Transfusion Strategies for Patients in Pediatric Intensive Care Units [Internet]. Vol. 356, n engl j med. 2007. Available from: www.nejm.org DOI: https://doi.org/10.1056/NEJMoa066240

Willems A, Harrington K, Lacroix J, Biarent D, Joffe AR, Wensley D, et al. Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: A subgroup analysis. Crit Care Med. 2010;38(2):649–56. DOI: https://doi.org/10.1097/CCM.0b013e3181bc816c

Maitland K, Kiguli S, Olupot-Olupot P, Engoru C, Mallewa M, Saramago Goncalves P, et al. Immediate Transfusion in African Children with Uncomplicated Severe Anemia. New England Journal of Medicine. 2019 Aug 1;381(5):407–19. DOI: https://doi.org/10.1056/NEJMoa1900105

Nunez TC, Voskresensky I V., Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: Simple as ABC (Assessment of Blood Consumption)? Journal of Trauma - Injury, Infection and Critical Care. 2009;66(2):346–52. DOI: https://doi.org/10.1097/TA.0b013e3181961c35

ACS TQIP Massive Transfusion in Trauma Guidelines https://www.facs.org/media/zcjdtrd1/transfusion_guildelines.pdf . Accessed September 7,2023

Weiss G, Ganz T, Goodnough LT. Review Series IRON METABOLISM AND ITS DISORDERS Anemia of inflammation [Internet]. 2019. Available from: www.bloodjournal.org DOI: https://doi.org/10.1182/blood-2018-06-856500

Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. Vol. 135, British Journal of Haematology. 2006. p. 634–41. DOI: https://doi.org/10.1111/j.1365-2141.2006.06355.x

Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: The PROPPR randomized clinical trial. JAMA - Journal of the American Medical Association. 2015 Feb 3;313(5):471–82.

Patil V, Shetmahajan M. Massive transfusion and massive transfusion protocol. Vol. 58, Indian Journal of Anaesthesia. Indian Society of Anaesthetists; 2014. p. 590–5. DOI: https://doi.org/10.4103/0019-5049.144662

Hendrickson JE, Roubinian NH, Chowdhury D, Brambilla D, Murphy EL, Wu Y, et al. Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication. Transfusion (Paris). 2016 Oct 1;56(10):2587–96. DOI: https://doi.org/10.1111/trf.13730

Ackfeld T, Schmutz T, Guechi Y, Le Terrier C. Blood Transfusion Reactions—A Comprehensive Review of the Literature including a Swiss Perspective. Vol. 11, Journal of Clinical Medicine. MDPI; 2022. DOI: https://doi.org/10.3390/jcm11102859

Panch SR, Montemayor-Garcia C, Klein HG. Hemolytic Transfusion Reactions. Longo DL, editor. New England Journal of Medicine [Internet]. 2019 Jul 11;381(2):150–62. Available from: http://www.nejm.org/doi/10.1056/NEJMra1802338 DOI: https://doi.org/10.1056/NEJMra1802338

Worel N. ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation. Vol. 43, Transfusion Medicine and Hemotherapy. S. Karger AG; 2016. p. 3–12. DOI: https://doi.org/10.1159/000441507

Gniadek TJ, McGonigle AM, Shirey RS, Brunker PA, Streiff M, Philosophe B, et al. A rare, potentially life-threatening presentation of passenger lymphocyte syndrome. Transfusion (Paris). 2017 May 1;57(5):1262–6. DOI: https://doi.org/10.1111/trf.14055

Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB* [Internet]. 2012. Available from: www.annals.org DOI: https://doi.org/10.7326/0003-4819-156-12-201206190-00429

AuBuchon JP, Dzik WS. Reports on clinical transfusion medicine in the early days of TRANSFUSION. Vol. 50, Transfusion. 2010. p. 963–7. DOI: https://doi.org/10.1111/j.1537-2995.2009.02457.x

Blumberg N, Heal JM, Gettings KF, Phipps RP, Masel D, Refaai MA, et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion (Paris). 2010 Dec;50(12):2738–44. DOI: https://doi.org/10.1111/j.1537-2995.2010.02748.x

Clifford L, Jia Q, Subramanian A, Yadav H, Schroeder DR, Kor DJ. Risk Factors and Clinical Outcomes Associated with Perioperative Transfusion-associated Circulatory Overload. Anesthesiology. 2017 Mar 1;126(3):409–18. DOI: https://doi.org/10.1097/ALN.0000000000001506

Moore SB, Foss ML. Ordering Blood for the Wrong Patient - Getting Inside the Minds of Ordering Physicians. Mayo Clin Proc. 2003;78(11):1337–9. DOI: https://doi.org/10.4065/78.11.1337

Bolton-Maggs PHB, Wood EM, Wiersum-Osselton JC. Wrong blood in tube - potential for serious outcomes: Can it be prevented? Vol. 168, British Journal of Haematology. Blackwell Publishing Ltd; 2015. p. 3–13. DOI: https://doi.org/10.1111/bjh.13137

Noizat-Pirenne F, Habibi A, Mekontso-Dessap A, Razazi K, Chadebech P, Mahevas M, et al. The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease. Vox Sang. 2015 Apr 1;108(3):262–7. DOI: https://doi.org/10.1111/vox.12217

Aul P, Ébert CH, Eorge G, Ells W, Lajchman OAB, Ohn J, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care abstract. Vol. 340. 1999. DOI: https://doi.org/10.1056/NEJM199904013401322

49.Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock. New England Journal of Medicine. 2014 Oct 9;371(15):1381–91. DOI: https://doi.org/10.1056/NEJMoa1406617

Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, et al. Transfusion Strategies for Acute Upper Gastrointestinal Bleeding. New England Journal of Medicine. 2013 Jan 3;368(1):11–21. DOI: https://doi.org/10.1056/NEJMoa1211801

Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, Cachanado M, Durand-Zaleski I, et al. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events among Patients with Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial. JAMA - Journal of the American Medical Association. 2021 Feb 9;325(6):552–60. DOI: https://doi.org/10.1001/jama.2021.0135

Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, et al. Liberal or Restrictive Transfusion after Cardiac Surgery. New England Journal of Medicine. 2015 Mar 12;372(11):997–1008. DOI: https://doi.org/10.1056/NEJMoa1403612

Palmieri TL, Holmes JH, Arnoldo B, Peck M, Potenza B, Cochran A, et al. Transfusion Requirement in Burn Care Evaluation (TRIBE). In: Annals of Surgery. Lippincott Williams and Wilkins; 2017. p. 595–602. DOI: https://doi.org/10.1097/SLA.0000000000002408

Fatalities Reported to FDA Following Blood Collection and Transfusion Annual Summary for Fiscal Year 2019. Accessed September 4, 2023

Transfusion-associated circulatory overload (TACO) Definition - 2018 (aabb.org). Accessed September 4, 2023.

Fatalities Reported to FDA Following Blood Collection and Transfusion Annual Summary for FY2020. Accessed September 3, 2023